The global market for Felodipine Extended-Release Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Glucosamine Sulfate Chondroitin is a dietary supplement commonly used for bone and joint health care, usually used to relieve joint pain and improve joint function. Its main ingredients include glucosamine (Glucosamine) and chondroitin sulfate (Chondroitin Sulfate).

North American market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Felodipine Extended-Release Tablets include Movefree, Pfizer, Watsons, Doppelherz, AdvaCare, By-Health, Blackmores, KAL, Schiff, Zhejiang Cheng Yi Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Felodipine Extended-Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Felodipine Extended-Release Tablets.

The Felodipine Extended-Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Felodipine Extended-Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Felodipine Extended-Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Felodipine Extended-Release Tablets Market Report

Report Metric	Details
Report Name	Felodipine Extended-Release Tablets Market
Segment by Type	Tablets Capsules
Segment by Application	Hospital Clinic Pharmacy
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Movefree, Pfizer, Watsons, Doppelherz, AdvaCare, By-Health, Blackmores, KAL, Schiff, Zhejiang Cheng Yi Pharmaceutical, CSPC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Felodipine Extended-Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Felodipine Extended-Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Felodipine Extended-Release Tablets Market report?

Ans: The main players in the Felodipine Extended-Release Tablets Market are Movefree, Pfizer, Watsons, Doppelherz, AdvaCare, By-Health, Blackmores, KAL, Schiff, Zhejiang Cheng Yi Pharmaceutical, CSPC

What are the Application segmentation covered in the Felodipine Extended-Release Tablets Market report?

Ans: The Applications covered in the Felodipine Extended-Release Tablets Market report are Hospital, Clinic, Pharmacy

What are the Type segmentation covered in the Felodipine Extended-Release Tablets Market report?

Ans: The Types covered in the Felodipine Extended-Release Tablets Market report are Tablets, Capsules

1 Felodipine Extended-Release Tablets Market Overview

1.1 Product Definition

1.2 Felodipine Extended-Release Tablets by Type

1.2.1 Global Felodipine Extended-Release Tablets Market Value Comparison by Type (2024 VS 2031)

1.2.2 Tablets

1.2.3 Capsules

1.3 Felodipine Extended-Release Tablets by Application

1.3.1 Global Felodipine Extended-Release Tablets Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Pharmacy

1.4 Global Felodipine Extended-Release Tablets Market Size Estimates and Forecasts

1.4.1 Global Felodipine Extended-Release Tablets Revenue 2020-2031

1.4.2 Global Felodipine Extended-Release Tablets Sales 2020-2031

1.4.3 Global Felodipine Extended-Release Tablets Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Felodipine Extended-Release Tablets Market Competition by Manufacturers

2.1 Global Felodipine Extended-Release Tablets Sales Market Share by Manufacturers (2020-2025)

2.2 Global Felodipine Extended-Release Tablets Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Felodipine Extended-Release Tablets Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Felodipine Extended-Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Felodipine Extended-Release Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Felodipine Extended-Release Tablets, Product Type & Application

2.7 Global Key Manufacturers of Felodipine Extended-Release Tablets, Date of Enter into This Industry

2.8 Global Felodipine Extended-Release Tablets Market Competitive Situation and Trends

2.8.1 Global Felodipine Extended-Release Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Felodipine Extended-Release Tablets Players Market Share by Revenue

2.8.3 Global Felodipine Extended-Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Felodipine Extended-Release Tablets Market Scenario by Region

3.1 Global Felodipine Extended-Release Tablets Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Felodipine Extended-Release Tablets Sales by Region: 2020-2031

3.2.1 Global Felodipine Extended-Release Tablets Sales by Region: 2020-2025

3.2.2 Global Felodipine Extended-Release Tablets Sales by Region: 2026-2031

3.3 Global Felodipine Extended-Release Tablets Revenue by Region: 2020-2031

3.3.1 Global Felodipine Extended-Release Tablets Revenue by Region: 2020-2025

3.3.2 Global Felodipine Extended-Release Tablets Revenue by Region: 2026-2031

3.4 North America Felodipine Extended-Release Tablets Market Facts & Figures by Country

3.4.1 North America Felodipine Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Felodipine Extended-Release Tablets Sales by Country (2020-2031)

3.4.3 North America Felodipine Extended-Release Tablets Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Felodipine Extended-Release Tablets Market Facts & Figures by Country

3.5.1 Europe Felodipine Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Felodipine Extended-Release Tablets Sales by Country (2020-2031)

3.5.3 Europe Felodipine Extended-Release Tablets Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Felodipine Extended-Release Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Felodipine Extended-Release Tablets Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Felodipine Extended-Release Tablets Sales by Region (2020-2031)

3.6.3 Asia Pacific Felodipine Extended-Release Tablets Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Felodipine Extended-Release Tablets Market Facts & Figures by Country

3.7.1 Latin America Felodipine Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Felodipine Extended-Release Tablets Sales by Country (2020-2031)

3.7.3 Latin America Felodipine Extended-Release Tablets Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Felodipine Extended-Release Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Felodipine Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2020-2031)

3.8.3 Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Felodipine Extended-Release Tablets Sales by Type (2020-2031)

4.1.1 Global Felodipine Extended-Release Tablets Sales by Type (2020-2025)

4.1.2 Global Felodipine Extended-Release Tablets Sales by Type (2026-2031)

4.1.3 Global Felodipine Extended-Release Tablets Sales Market Share by Type (2020-2031)

4.2 Global Felodipine Extended-Release Tablets Revenue by Type (2020-2031)

4.2.1 Global Felodipine Extended-Release Tablets Revenue by Type (2020-2025)

4.2.2 Global Felodipine Extended-Release Tablets Revenue by Type (2026-2031)

4.2.3 Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2020-2031)

4.3 Global Felodipine Extended-Release Tablets Price by Type (2020-2031)

5 Segment by Application

5.1 Global Felodipine Extended-Release Tablets Sales by Application (2020-2031)

5.1.1 Global Felodipine Extended-Release Tablets Sales by Application (2020-2025)

5.1.2 Global Felodipine Extended-Release Tablets Sales by Application (2026-2031)

5.1.3 Global Felodipine Extended-Release Tablets Sales Market Share by Application (2020-2031)

5.2 Global Felodipine Extended-Release Tablets Revenue by Application (2020-2031)

5.2.1 Global Felodipine Extended-Release Tablets Revenue by Application (2020-2025)

5.2.2 Global Felodipine Extended-Release Tablets Revenue by Application (2026-2031)

5.2.3 Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2020-2031)

5.3 Global Felodipine Extended-Release Tablets Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Movefree

6.1.1 Movefree Company Information

6.1.2 Movefree Description and Business Overview

6.1.3 Movefree Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Movefree Felodipine Extended-Release Tablets Product Portfolio

6.1.5 Movefree Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Felodipine Extended-Release Tablets Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Watsons

6.3.1 Watsons Company Information

6.3.2 Watsons Description and Business Overview

6.3.3 Watsons Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Watsons Felodipine Extended-Release Tablets Product Portfolio

6.3.5 Watsons Recent Developments/Updates

6.4 Doppelherz

6.4.1 Doppelherz Company Information

6.4.2 Doppelherz Description and Business Overview

6.4.3 Doppelherz Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Doppelherz Felodipine Extended-Release Tablets Product Portfolio

6.4.5 Doppelherz Recent Developments/Updates

6.5 AdvaCare

6.5.1 AdvaCare Company Information

6.5.2 AdvaCare Description and Business Overview

6.5.3 AdvaCare Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.5.4 AdvaCare Felodipine Extended-Release Tablets Product Portfolio

6.5.5 AdvaCare Recent Developments/Updates

6.6 By-Health

6.6.1 By-Health Company Information

6.6.2 By-Health Description and Business Overview

6.6.3 By-Health Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.6.4 By-Health Felodipine Extended-Release Tablets Product Portfolio

6.6.5 By-Health Recent Developments/Updates

6.7 Blackmores

6.7.1 Blackmores Company Information

6.7.2 Blackmores Description and Business Overview

6.7.3 Blackmores Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Blackmores Felodipine Extended-Release Tablets Product Portfolio

6.7.5 Blackmores Recent Developments/Updates

6.8 KAL

6.8.1 KAL Company Information

6.8.2 KAL Description and Business Overview

6.8.3 KAL Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.8.4 KAL Felodipine Extended-Release Tablets Product Portfolio

6.8.5 KAL Recent Developments/Updates

6.9 Schiff

6.9.1 Schiff Company Information

6.9.2 Schiff Description and Business Overview

6.9.3 Schiff Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Schiff Felodipine Extended-Release Tablets Product Portfolio

6.9.5 Schiff Recent Developments/Updates

6.10 Zhejiang Cheng Yi Pharmaceutical

6.10.1 Zhejiang Cheng Yi Pharmaceutical Company Information

6.10.2 Zhejiang Cheng Yi Pharmaceutical Description and Business Overview

6.10.3 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio

6.10.5 Zhejiang Cheng Yi Pharmaceutical Recent Developments/Updates

6.11 CSPC

6.11.1 CSPC Company Information

6.11.2 CSPC Description and Business Overview

6.11.3 CSPC Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.11.4 CSPC Felodipine Extended-Release Tablets Product Portfolio

6.11.5 CSPC Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Felodipine Extended-Release Tablets Industry Chain Analysis

7.2 Felodipine Extended-Release Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Felodipine Extended-Release Tablets Production Mode & Process Analysis

7.4 Felodipine Extended-Release Tablets Sales and Marketing

7.4.1 Felodipine Extended-Release Tablets Sales Channels

7.4.2 Felodipine Extended-Release Tablets Distributors

7.5 Felodipine Extended-Release Tablets Customer Analysis

8 Felodipine Extended-Release Tablets Market Dynamics

8.1 Felodipine Extended-Release Tablets Industry Trends

8.2 Felodipine Extended-Release Tablets Market Drivers

8.3 Felodipine Extended-Release Tablets Market Challenges

8.4 Felodipine Extended-Release Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Zhejiang Cheng Yi Pharmaceutical

CSPC

Movefree

List of Tables

Table 1. Global Felodipine Extended-Release Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Felodipine Extended-Release Tablets Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Felodipine Extended-Release Tablets Market Competitive Situation by Manufacturers in 2024

Table 4. Global Felodipine Extended-Release Tablets Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Felodipine Extended-Release Tablets Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Felodipine Extended-Release Tablets Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Felodipine Extended-Release Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Felodipine Extended-Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Felodipine Extended-Release Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Felodipine Extended-Release Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Felodipine Extended-Release Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Felodipine Extended-Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Felodipine Extended-Release Tablets as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Felodipine Extended-Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Felodipine Extended-Release Tablets Sales by Region (2020-2025) & (K Units)

Table 18. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2020-2025)

Table 19. Global Felodipine Extended-Release Tablets Sales by Region (2026-2031) & (K Units)

Table 20. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2026-2031)

Table 21. Global Felodipine Extended-Release Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2020-2025)

Table 23. Global Felodipine Extended-Release Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2026-2031)

Table 25. North America Felodipine Extended-Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Felodipine Extended-Release Tablets Sales by Country (2020-2025) & (K Units)

Table 27. North America Felodipine Extended-Release Tablets Sales by Country (2026-2031) & (K Units)

Table 28. North America Felodipine Extended-Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Felodipine Extended-Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Felodipine Extended-Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Felodipine Extended-Release Tablets Sales by Country (2020-2025) & (K Units)

Table 32. Europe Felodipine Extended-Release Tablets Sales by Country (2026-2031) & (K Units)

Table 33. Europe Felodipine Extended-Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Felodipine Extended-Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Felodipine Extended-Release Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Felodipine Extended-Release Tablets Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Felodipine Extended-Release Tablets Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Felodipine Extended-Release Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Felodipine Extended-Release Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Felodipine Extended-Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Felodipine Extended-Release Tablets Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Felodipine Extended-Release Tablets Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Felodipine Extended-Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Felodipine Extended-Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Felodipine Extended-Release Tablets Sales (K Units) by Type (2020-2025)

Table 51. Global Felodipine Extended-Release Tablets Sales (K Units) by Type (2026-2031)

Table 52. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2020-2025)

Table 53. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2026-2031)

Table 54. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2020-2025)

Table 57. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2026-2031)

Table 58. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Type (2020-2025)

Table 59. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Type (2026-2031)

Table 60. Global Felodipine Extended-Release Tablets Sales (K Units) by Application (2020-2025)

Table 61. Global Felodipine Extended-Release Tablets Sales (K Units) by Application (2026-2031)

Table 62. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2020-2025)

Table 63. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2026-2031)

Table 64. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2020-2025)

Table 67. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2026-2031)

Table 68. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Application (2020-2025)

Table 69. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Application (2026-2031)

Table 70. Movefree Company Information

Table 71. Movefree Description and Business Overview

Table 72. Movefree Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Movefree Felodipine Extended-Release Tablets Product

Table 74. Movefree Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Felodipine Extended-Release Tablets Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Watsons Company Information

Table 81. Watsons Description and Business Overview

Table 82. Watsons Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Watsons Felodipine Extended-Release Tablets Product

Table 84. Watsons Recent Developments/Updates

Table 85. Doppelherz Company Information

Table 86. Doppelherz Description and Business Overview

Table 87. Doppelherz Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Doppelherz Felodipine Extended-Release Tablets Product

Table 89. Doppelherz Recent Developments/Updates

Table 90. AdvaCare Company Information

Table 91. AdvaCare Description and Business Overview

Table 92. AdvaCare Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. AdvaCare Felodipine Extended-Release Tablets Product

Table 94. AdvaCare Recent Developments/Updates

Table 95. By-Health Company Information

Table 96. By-Health Description and Business Overview

Table 97. By-Health Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. By-Health Felodipine Extended-Release Tablets Product

Table 99. By-Health Recent Developments/Updates

Table 100. Blackmores Company Information

Table 101. Blackmores Description and Business Overview

Table 102. Blackmores Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Blackmores Felodipine Extended-Release Tablets Product

Table 104. Blackmores Recent Developments/Updates

Table 105. KAL Company Information

Table 106. KAL Description and Business Overview

Table 107. KAL Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. KAL Felodipine Extended-Release Tablets Product

Table 109. KAL Recent Developments/Updates

Table 110. Schiff Company Information

Table 111. Schiff Description and Business Overview

Table 112. Schiff Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Schiff Felodipine Extended-Release Tablets Product

Table 114. Schiff Recent Developments/Updates

Table 115. Zhejiang Cheng Yi Pharmaceutical Company Information

Table 116. Zhejiang Cheng Yi Pharmaceutical Description and Business Overview

Table 117. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product

Table 119. Zhejiang Cheng Yi Pharmaceutical Recent Developments/Updates

Table 120. CSPC Company Information

Table 121. CSPC Description and Business Overview

Table 122. CSPC Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. CSPC Felodipine Extended-Release Tablets Product

Table 124. CSPC Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Felodipine Extended-Release Tablets Distributors List

Table 128. Felodipine Extended-Release Tablets Customers List

Table 129. Felodipine Extended-Release Tablets Market Trends

Table 130. Felodipine Extended-Release Tablets Market Drivers

Table 131. Felodipine Extended-Release Tablets Market Challenges

Table 132. Felodipine Extended-Release Tablets Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Felodipine Extended-Release Tablets

Figure 2. Global Felodipine Extended-Release Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Felodipine Extended-Release Tablets Market Share by Type: 2024 & 2031

Figure 4. Tablets Product Picture

Figure 5. Capsules Product Picture

Figure 6. Global Felodipine Extended-Release Tablets Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Felodipine Extended-Release Tablets Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Pharmacy

Figure 11. Global Felodipine Extended-Release Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Felodipine Extended-Release Tablets Market Size (2020-2031) & (US$ Million)

Figure 13. Global Felodipine Extended-Release Tablets Sales (2020-2031) & (K Units)

Figure 14. Global Felodipine Extended-Release Tablets Average Price (US$/Unit) & (2020-2031)

Figure 15. Felodipine Extended-Release Tablets Report Years Considered

Figure 16. Felodipine Extended-Release Tablets Sales Share by Manufacturers in 2024

Figure 17. Global Felodipine Extended-Release Tablets Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Felodipine Extended-Release Tablets Players: Market Share by Revenue in Felodipine Extended-Release Tablets in 2024

Figure 19. Felodipine Extended-Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Felodipine Extended-Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Felodipine Extended-Release Tablets Sales Market Share by Country (2020-2031)

Figure 22. North America Felodipine Extended-Release Tablets Revenue Market Share by Country (2020-2031)

Figure 23. United States Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Felodipine Extended-Release Tablets Sales Market Share by Country (2020-2031)

Figure 26. Europe Felodipine Extended-Release Tablets Revenue Market Share by Country (2020-2031)

Figure 27. Germany Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Felodipine Extended-Release Tablets Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Felodipine Extended-Release Tablets Revenue Market Share by Region (2020-2031)

Figure 34. China Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Felodipine Extended-Release Tablets Sales Market Share by Country (2020-2031)

Figure 42. Latin America Felodipine Extended-Release Tablets Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Felodipine Extended-Release Tablets Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Felodipine Extended-Release Tablets Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Felodipine Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Felodipine Extended-Release Tablets by Type (2020-2031)

Figure 53. Global Revenue Market Share of Felodipine Extended-Release Tablets by Type (2020-2031)

Figure 54. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Felodipine Extended-Release Tablets by Application (2020-2031)

Figure 56. Global Revenue Market Share of Felodipine Extended-Release Tablets by Application (2020-2031)

Figure 57. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Application (2020-2031)

Figure 58. Felodipine Extended-Release Tablets Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions